Rameen Beroukhim, M.D., Ph.D.
Associate Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical School. Associate member of the Broad Institute of Harvard and MIT
Dr. Beroukhim is an associate professor of medicine at the Dana-Farber Cancer Institute and Harvard Medical School, and an associate member of the Broad Institute of Harvard and MIT. In…
Dr. Beroukhim is an associate professor of medicine at the Dana-Farber Cancer Institute and Harvard Medical School, and an associate member of the Broad Institute of Harvard and MIT. In addition to directing a genomics-focused lab, he sees patients in an adult neuro-oncology clinic. Dr. Beroukhim studied physics and philosophy at the University of California, Berkeley. He obtained an M.Phil and Ph.D. from the University of Cambridge for work done at the Medical Research Council Laboratory of Medical Biology on electron crystallographic studies of ion channels. He then completed his M.D. and internal medicine residency at the University of California, San Francisco, before completing a medical oncology fellowship at Dana-Farber Cancer Institute and Massachusetts General Hospital. Dr. Beroukhim’s research focuses on the development and use of genomic and computational technologies to understand tumor evolution and vulnerabilities, with particular emphases on brain cancers and on alterations in chromosome structure across cancers. Dr. Beroukhim has published over 300 papers, including the first comprehensive analyses of cancer-specific dependencies due to genomic losses.